• Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose—a randomized controlled trial 

      Skulberg, Arne Kristian; Åsberg, Anders; Zare, Hasse Khiabani; Røstad, Hilde; Tylleskär, Ida; Dale, Ola (Peer reviewed; Journal article, 2019)
      Background and aims Intranasal (i.n.) naloxone is an established treatment for opioid overdose. Anyone likely to witness an overdose should have access to the antidote. We aimed to determine whether an i.n. formulation ...
    • Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation 

      Traaen, Gunn Marit; Øverland, Britt; Aakerøy, Lars; Hunt, Tove Elizabeth Frances; Bendz, Christina; Leif Magne, Sande; Aakhus, Svend; Zare, Hasse Khiabani; Steinshamn, Sigurd Loe; Anfinsen, Ole-Gunnar; Loennechen, Jan Pål; Gullestad, Lars; Akre, Harriet (Peer reviewed; Journal article, 2019)
      Background Recent studies have suggested an association between sleep apnea (SA) and atrial fibrillation (AF). We aimed to study the prevalence, characteristics, risk factors and type of sleep apnea (SA) in ablation ...
    • Treatment of sleep apnea in patients with paroxysmal atrial fibrillation: design and rationale of a randomized controlled trial 

      Traaen, Gunn Marit; Aakerøy, Lars; Hunt, Tove Elisabeth F.; Øverland, Britt; Lyseggen, Erik; Aukrust, Pål; Ueland, Thor; Helle-Valle, Thomas Michael; Steinshamn, Sigurd Loe; Edvardsen, Thor; Zare, Hasse Khiabani; Aakhus, Svend; Akre, Harriet; Anfinsen, Ole-Gunnar; Loennechen, Jan Pål; Gullestad, Lars (Journal article; Peer reviewed, 2018)
      Rationale. Atrial fibrillation is associated with increased mortality as well as morbidity. There is strong evidence for an association between atrial fibrillation and sleep apnea. It is not known whether treatment of sleep ...